American Beacon Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
American Beacon Advisors's AMGN Position: Q4 2018 in Review
American Beacon Advisors sold out of Amgen (AMGN) in Q4 2018, closing a stake of 2,237 shares — an estimated $464K sold.
American Beacon Advisors first reported a position in AMGN in Q1 2017 and held it in 7 quarters. The position peaked at $464K in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.
- American Beacon Advisors reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
- American Beacon Advisors sold 2,237 Amgen shares in Q4 2018, an estimated $464K.
- American Beacon Advisors first reported a position in Amgen in Q1 2017 and held it in 7 quarters.
- American Beacon Advisors's Amgen position peaked at $464K in Q3 2018.
- 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.
Based on American Beacon Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.